ACTRN12606000327583已完成3 期
Docosahexaenoic Acid (DHA) for the Improvement of Neurodevelopmental Outcome in Preterm Infants.
ational Health and Medical Research Council0 个研究点目标入组 657 人开始时间: 2003年3月27日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 657
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 32 Weeks（—）
- 性别
- All
入选标准
- •1. Infants born < or = 32 weeks gestation 2. Signed written informed consent 3. Family/guardians who speak English
排除标准
- •1. Infants with major congenital or chromosomal abnormalities 2. More than 5 days after commencing enteral feeds 3. Lactating mother with blood clotting disorder where tuna oil is contraindicated or regularly taking anticoagulant therapy 4. Participation in other clinical trials involving fatty acid intervention 5. Geographic location 6. Multiple births where not all live born infants are eligible.
研究者
相似试验
已完成
3 期
Effect of omega 3 fatty acid (DHA) Supplementation during pregnancy on newborn birth weight and gestational age .CTRI/2013/04/003540Department of Science and Technology957
进行中（未招募）
不适用
Effect of Docosahexaenoic Acid (DHA) use on the incidence of eye disease of preterm babiesC11.768Retinopathy of PrematurityRBR-523wzcbSecretaria Estadual da Saúde de Santa Catarina
招募中
4 期
Fish oil in chronic psychiatric outpatients with anxiety and mood disorders.ACTRN12614000390684Dr Michael Piperoglou60
已完成
不适用
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosaRetinitis PigmentosaNCT00004827Retina Foundation of the Southwest46
进行中（未招募）
不适用
Dietary polyunsaturated fatty acids for decreasing lipid hepatic content in children with fatty liveronalcoholic steatohepatitisMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-001975-36-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA